“I hope that one day I’m able to increase our understanding of evolution, and I also hope to increase access to research. I want others to know that this space is open to people who look like me, who come from disadvantaged backgrounds, and who are underrepresented in the sciences,” says Nkrumah Grant, Ph.D., a postdoctoral research associate (postdoc) in microbiology and molecular genetics at Michigan State University (MSU) in East Lansing.

Dr. Grant’s work receives support from the NIGMS Diversity Supplement Program (DSP), which is designed to improve the recruitment and training of promising researchers from diverse backgrounds. Diversifying the scientific workforce can lead to new approaches to research questions, increased recruitment of diverse volunteers for clinical studies, an improved capacity to address health disparities, and many other benefits.

At least 1.7 million adults in the United States develop a life-threatening condition called sepsis each year. Sepsis is an overwhelming or impaired whole-body immune response that’s most often caused by bacterial infections. However, it can also be caused by viral infections, such as COVID-19 or influenza; fungal infections; or other injuries, including physical trauma.​​ Anyone can get sepsis, but there’s a higher risk for some people, such as those who are ages 65 and older, who have certain medical conditions, or who have recently experienced severe illness or hospitalization.

The early symptoms of sepsis can include fever, chills, rapid breathing or heart rate, disorientation, and clammy or sweaty skin. Because other conditions also have these symptoms, sepsis can be difficult to diagnose. NIGMS-supported researchers are working to increase our understanding of sepsis so that doctors can identify it more quickly and treat it more effectively.

Have you ever wondered what happens inside your body when you take a medicine? An area of pharmacology called pharmacokinetics is the study of precisely that. Here, we follow a medicine as it enters the body, finds its therapeutic target (also called the active site), and then eventually leaves the body.

To begin, a person takes or is given a dose of medicine by a particular route of administration, such as by mouth (oral); through the skin (topical), mucous membranes
(nasal), or lungs (inhaled); or through a needle into a muscle (intramuscular) or into a vein (intravenous). Sometimes medicines can be administered right where they’re needed, like a topical antibiotic ointment on a scrape, but most medicines need to enter the blood to reach their therapeutic target and be effective. Those are the ones we’ll continue following, using the common pharmacokinetic acronym ADME:

This August marks 10 years of the blog! Throughout the past decade, we’ve brought you blog posts that explore basic science topics, quiz your knowledge, showcase cool images, and more! Some of our most-read favorites include:

Pharmacology is the study of how molecules, such as medicines, interact with the body. Scientists who study pharmacology are called pharmacologists, and they explore the chemical properties, biological effects, and therapeutic uses of medicines and other molecules. Their work can be broken down into two main areas:

• Pharmacokinetics is the study of how the body acts on a medicine, including its processes of absorption, distribution, metabolism, and excretion (ADME).
• Pharmacodynamics is the study of how a medicine acts in the body—both on its intended target and throughout all the organs and tissues in the body.

While she was in graduate school, Mandy Muller, Ph.D., became intrigued with viruses that are oncogenic, meaning they can cause cancer. At the time, she was researching human papillomaviruses (HPVs), which can lead to cervical and throat cancer, among other types. Now, as an assistant professor of microbiology at the University of Massachusetts (UMass) Amherst, Dr. Muller studies Kaposi sarcoma-associated herpesvirus (KSHV), which causes the rare AIDS-associated cancer Kaposi sarcoma.

A Continental Change

Dr. Muller has come a long way, both geographically and professionally, since her childhood in France. She was the first person in her family to graduate from high school, where she excelled in science, and went on to attend École Normale Supérieure (ENS) de Lyon, a research-oriented undergraduate institution in Lyon, France. “We spent weeks at a time in laboratory-based classes, working in real labs. That’s when I realized people could do research full-time, which caught my attention,” says Dr. Muller. She double-majored in biology and geology, and soon chose to focus her career on immunology and virology.

“It’s so fun to try to make meaning from a confusing experimental result and talk to other scientists who are excited by the same questions you are,” says Elizabeth Wayne, Ph.D., an assistant professor of biomedical engineering and chemical engineering at Carnegie Mellon University (CMU) in Pittsburgh, Pennsylvania. We talked to Dr. Wayne about her career trajectory, research on immune cells, and belief that scientists can change the world.

Q: How did you first become interested in science?

The power of computer code has been a longtime fascination for Tomas Helikar, Ph.D., a professor of biochemistry at the University of Nebraska-Lincoln (UNL). In college, when he learned he could use that power to help researchers better understand biology and improve human health, Dr. Helikar knew he’d found his ideal career. Since then, he’s built a successful team of scientists studying the ways we can use mathematical models in biomedical research, such as creating a digital replica of the immune system that could predict how a patient will react to infectious microorganisms and other pathogenic insults.

A Career in Computational Biology

Dr. Helikar first became involved in computer science by learning how to build a website as a high school student. He was amazed to learn that simple lines of computer code could be converted into a functional website, and he felt empowered knowing that he had created a real product from his computer.